These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 17346686)

  • 1. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
    Oka M; Karoor V; Homma N; Nagaoka T; Sakao E; Golembeski SM; Limbird J; Imamura M; Gebb SA; Fagan KA; McMurtry IF
    Cardiovasc Res; 2007 Jun; 74(3):377-87. PubMed ID: 17346686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
    Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHEA treatment of pulmonary hypertension: new insights into a complex mechanism.
    Dubuis E
    Cardiovasc Res; 2007 Jun; 74(3):337-8. PubMed ID: 17466961
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.
    Thébaud B; Petit T; De Lagausie P; Dall'Ava-Santucci J; Mercier JC; Dinh-Xuan AT
    Am J Respir Cell Mol Biol; 2002 Jul; 27(1):42-7. PubMed ID: 12091244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
    Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
    Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
    Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
    Tan JX; Huang XL; Wang B; Fang X; Huang DN
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.
    Casey DB; Badejo AM; Dhaliwal JS; Sikora JL; Fokin A; Golwala NH; Greco AJ; Murthy SN; Nossaman BD; Hyman AL; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H184-92. PubMed ID: 20435851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats.
    Karamsetty MR; Klinger JR; Hill NS
    J Pharmacol Exp Ther; 2001 Jun; 297(3):968-74. PubMed ID: 11356918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.
    Thorsen LB; Eskildsen-Helmond Y; Zibrandtsen H; Stasch JP; Simonsen U; Laursen BE
    Eur J Pharmacol; 2010 Nov; 647(1-3):147-54. PubMed ID: 20828552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged nitric oxide inhalation during recovery from chronic hypoxia does not decrease nitric oxide-dependent relaxation in pulmonary arteries.
    Maruyama J; Jiang BH; Maruyama K; Takata M; Miyasaka K
    Chest; 2004 Dec; 126(6):1919-25. PubMed ID: 15596693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
    Scott WS; Nakayama DK
    J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.
    Ruiz-Torres MP; Griera M; Chamorro A; Díez-Marqués ML; Rodríguez-Puyol D; Rodríguez-Puyol M
    Cardiovasc Res; 2009 Apr; 82(1):125-32. PubMed ID: 19126601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
    Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
    PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
    Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
    Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.